Should You Buy Brookfield Corp (BN) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Buy
Latest Price
47.090
1 Day change
-0.70%
52 Week Range
49.560
Analysis Updated At
2026/01/28
Buy BN now for a beginner, long-term investor with $50k–$100k. The stock is sitting right on its pivot/support area (~46.73), while Wall Street sentiment and price targets have been moving higher (roughly $52–$59). The near-term technicals are slightly soft, but not broken, and the news flow (AI infrastructure fund targeting up to $100B of assets) provides a clear multi-year growth catalyst that fits a long-term approach.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock today.
Technical Analysis
Trend is mildly bearish/sideways at the moment:
- MACD histogram is below zero (-0.0773) and expanding negatively → downside momentum is building modestly.
- RSI(6) ~45.3 → neutral, not oversold (so no strong “bounce” signal yet).
- Moving averages are converging → consolidation/indecision rather than a clean uptrend.
- Key levels: Pivot 46.726 (price ~46.74 is essentially at pivot). Support S1 45.604 then S2 44.91. Resistance R1 47.849 then R2 48.543.
Interpretation: This is an acceptable long-term entry because price is near support (good risk location), but the short-term tape is not showing strong upside momentum yet.
Options Data
Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Options sentiment is mixed:
- Open Interest put/call ratio = 0.55 → positioning skewed more bullish (more call OI than put OI).
- Option volume put/call ratio = 24.47 with put volume 3,890 vs call volume 159 → strong short-term demand for puts (near-term hedging or bearish speculation).
- IV is low (IV percentile 4.8; 30D IV ~24.38) → options are relatively cheap vs the stock’s recent history, often consistent with complacency or reduced expected volatility.
Takeaway: Longer-positioning looks constructive (OI), but today’s flow is heavily put-dominant (near-term caution). For a long-term buyer, this doesn’t negate the buy, but it suggests choppiness is likely.
Technical Summary
Sell
3
Buy
8
Positive Catalysts
3) Potential earnings catalyst ahead: Next earnings (QDEC 2025) on 2026-02-12 pre-market; positive commentary around deal activity and carried interest realizations could help sentiment.
Neutral/Negative Catalysts
1) Technical momentum: MACD is negative and worsening, implying the near-term trend could drift lower before stabilizing.
3) Recent fundamentals quality: Revenue declined YoY and gross margin compressed (see financials), which can cap near-term multiple expansion.
4) Pattern-based forecast provided: Similar-pattern model suggests a negative bias over the next month (-4.24%), implying timing risk if buying immediately.
Financial Performance
Latest reported quarter: 2025/Q3.
- Revenue: $18.917B, down 8.27% YoY (top-line contraction).
- Net income: $177M, up 742.86% YoY (sharp improvement; likely mix/one-time items also contributing).
- EPS: $0.08, up 700% YoY (strong YoY growth off a low base).
- Gross margin: 22.65%, down 11.52% YoY (margin pressure).
Read-through: Earnings improved significantly YoY, but revenue and margins weakened—overall, fundamentals look “improving profitability but not clean broad-based growth” in the latest quarter.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend is clearly improving (bullish):
- Morgan Stanley (2026-01-27): Overweight; raised PT to $58 from $54 on expectations of supportive deal activity and higher EPS estimates.
- RBC Capital (2025-12-15): Outperform; raised PT to $58 from $57; named BN a Top Pick for 2026, citing upside catalysts (incl. carried interest realizations) with defensive attributes.
- TD Securities (2025-11-14): Buy; raised PT to $59 from $57; sees Brookfield extending its lead in AI infrastructure renewables.
- CIBC (2025-11-14): Outperformer; raised PT to $52 from $50.67; views execution as on-track.
Wall Street pros: consistent Buy/Outperform/Overweight ratings, rising price targets (low-$50s to high-$50s), and a clear thematic bull case around AI infrastructure + deal activity.
Wall Street cons: less emphasis in the notes provided, but the market’s past post-earnings selloff and the company’s revenue/margin pressure suggest execution and near-term sentiment can still swing.
Politicians/influential figures: No recent congress trading data available in the last 90 days.
Wall Street analysts forecast BN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BN is 49.91 USD with a low forecast of 36 USD and a high forecast of 59 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
Wall Street analysts forecast BN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BN is 49.91 USD with a low forecast of 36 USD and a high forecast of 59 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
0 Hold
0 Sell
Strong Buy
Current: 47.420
Low
36
Averages
49.91
High
59
Current: 47.420
Low
36
Averages
49.91
High
59
Morgan Stanley
NULL -> Overweight
maintain
$54 -> $58
AI Analysis
2026-01-27
New
Reason
Morgan Stanley
Price Target
$54 -> $58
AI Analysis
2026-01-27
New
maintain
NULL -> Overweight
Reason
Morgan Stanley raised the firm's price target on Brookfield Corp. to $58 from $54 and keeps an Overweight rating on the shares. Ramping deal activity should be supportive for the alternative asset managers into Q4 and 2026, says the analyst, who raised EPS estimates by 4% and 1% ahead of consensus on average among the group as part of the firm's Q4 earnings preview.
RBC Capital
Outperform
maintain
$57 -> $58
2025-12-15
Reason
RBC Capital
Price Target
$57 -> $58
2025-12-15
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Brookfield Corp. to $58 from $57 and keeps an Outperform rating on the shares as part of its broader research note previewing 2026 across North American Diversified Financials. The firm also names the stock its Top Pick for next year. Brookfield is among the companies that provide upside catalysts in 2026 in a favorable macro environment as well as defensive attributes in the event of macro volatility, the analyst tells investors in a research note. RBC adds that the market is still overly discounting the business despite tailwinds into 2026, most notably carried interest realizations.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BN
